Delegates from the member boards of pharmacy adopted six resolutions during the 121st National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held in Fort Lauderdale, FL, from May 13-16, 2025. The resolutions address the following:

  • Drugs Lost in Transit. NABP will work with federal agencies including Drug Enforcement Administration (DEA), Food and Drug Administration, United States Postal Service, shipping vendors, wholesale distributors, and reverse distributors to further study this issue to identify causes and develop effective strategies to minimize the incidence of drugs lost in transit, thereby safeguarding public health, safety, and welfare.
  • Joint Accountability for Pharmacy Compliance. NABP will develop best practices for member state boards on holding owners and/or permit holders and the designated supervising pharmacists and/or pharmacists-in-charge (PICs) jointly accountable for patient safety and compliance; and NABP will work with member boards and stakeholders to encourage that owners and/or permit holders and the designated supervising pharmacists and/or PICs collaboratively work with pharmacy staff to gather input on pharmacy compliance, resource needs, workflow processes, and patient safety concerns, and proactively develop solutions to enhance patient safety through increased compliance.
  • Payer/Processor Payment Rates and Methodologies Impacting Patient Safety. NABP shall be unencumbered and free to cite where appropriate when payer and/or processor payment rates and methodologies act as factors contributing to workforce challenges, burnout rates, worsened mental health impacting patient safety, and increased stress in the workplace.
  • Increasing Access to Medications for Opioid Use Disorder. NABP will partner with appropriate stakeholders, including Healthcare Distribution Alliance, Substance Abuse and Mental Health Services Administration, and others, to advocate for DEA to provide clear guidance to wholesale distributors and manufacturers of medications for opioid use disorder (MOUD) regarding pharmacy purchasing thresholds to ease patient suffering and improve access to MOUD; and NABP will advocate for the largest wholesale distributors to develop a standardized process for pharmacies to request increases in thresholds established for MOUD; and NABP will develop educational materials for its members to use to educate pharmacies on the process to request an increase in MOUD supply; and NABP will convene a task force to identify additional opportunities and recommend actions that NABP and its member boards of pharmacy can take to remove barriers limiting patient access to buprenorphine for use in the treatment of opioid use disorder.
  • Task Force to Examine the Use of the Test of English as a Foreign Language Internet-based Test (TOEFL iBT) as a Requirement for Foreign Pharmacy Graduate Examination Committee™ (FPGEC®) Certification. NABP will convene a task force to review the use of the TOEFL iBT as a requirement for FPGEC certification.

Additionally, a recognition resolution honoring members of the Association who have passed away was unanimously approved.

The complete text of the resolutions will be available in the Reports section on the NABP website.